STOWHEALTH — All Prescriptions & Medications — Page 10
Practice Code: D83044 | STOWMARKET, IP14 1NL
Showing results 451-500 of 787
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Clonidine hydrochloride | 47 | 7,644 | £735 | -11.9% ▼ |
| Levobunolol hydrochloride | 47 | 2,760 | £843 | +547.2% ▲ |
| 47 | 375 | £113 | +62.3% ▲ | |
| 47 | 1,973 | £3.6K | +39.2% ▲ | |
| 47 | 1,320 | £5.9K | +296.8% ▲ | |
| Sodium feredetate | 46 | 13.0K | £353 | +60.6% ▲ |
| Other selenium preparations | 46 | 322 | £22 | +387.3% ▲ |
| Menthol | 45 | 19.2K | £718 | +59.8% ▲ |
| Clindamycin phosphate | 45 | 1,590 | £287 | +173.6% ▲ |
| 45 | 1,577 | £420 | +34.8% ▲ | |
| Nefopam hydrochloride | 44 | 3,084 | £125 | -61.1% ▼ |
| Fesoterodine fumarate | 44 | 1,232 | £120 | +11.5% ▲ |
| RtS 3.3 - 4 kcal/ml energy with protein liquid (0913141) | 44 | 119.6K | £3.5K | +65.7% ▲ |
| Trandolapril | 43 | 2,100 | £359 | +313.5% ▲ |
| Chlorpromazine hydrochloride | 43 | 3,710 | £3.0K | +9.3% ▲ |
| Tapentadol | 43 | 2,385 | £2.2K | +4.5% ▲ |
| Betamethasone sodium phosphate | 43 | 430 | £180 | +66.0% ▲ |
| Hepatitis A/hepatitis B | 43 | 43 | £1.2K | +154.2% ▲ |
| 43 | 988 | £375 | -13.0% ▼ | |
| Vitamins caps | 42 | 1,176 | £20 | -23.6% ▼ |
| 42 | 43 | £525 | +320.1% ▲ | |
| Sucralfate | 41 | 20.7K | £23.0K | +388.2% ▲ |
| Salmeterol | 41 | 44 | £1.3K | +70.5% ▲ |
| Tiotropium bromide/olodaterol | 41 | 41 | £1.3K | -33.1% ▼ |
| Cyclizine lactate | 41 | 861 | £876 | +173.3% ▲ |
| Rotigotine | 40 | 1,120 | £4.1K | +48.2% ▲ |
| Canagliflozin | 40 | 1,172 | £1.5K | -72.1% ▼ |
| Trospium chloride | 40 | 2,161 | £572 | -21.7% ▼ |
| Adapalene | 40 | 1,800 | £618 | +82.7% ▲ |
| Fluorouracil (Sunscreen) | 40 | 1,550 | £1.3K | +9.8% ▲ |
| 40 | 622 | £1.9K | +1.7% vs avg | |
| Glyceryl trinitrate | 39 | 1,170 | £1.4K | +193.5% ▲ |
| Labetalol hydrochloride | 39 | 3,108 | £280 | +71.8% ▲ |
| Telmisartan | 39 | 1,092 | £213 | -32.7% ▼ |
| Oestrogens conjugated | 39 | 2,576 | £1.3K | +91.1% ▲ |
| 39 | 1,852 | £202 | -51.5% ▼ | |
| Indoramin | 38 | 2,670 | £2.3K | +150.0% ▲ |
| Cyproterone acetate | 38 | 1,274 | £1.6K | +246.1% ▲ |
| 38 | 499 | £264 | -62.8% ▼ | |
| 38 | 435 | £840 | -44.5% ▼ | |
| 38 | 2,592 | £977 | +96.6% ▲ | |
| 38 | 3,900 | £453 | +39.2% ▲ | |
| Imipramine hydrochloride | 37 | 4,144 | £154 | +45.1% ▲ |
| Safinamide | 37 | 1,067 | £2.3K | +83.7% ▲ |
| Mercaptopurine | 37 | 1,202 | £555 | +139.0% ▲ |
| 37 | 448 | £470 | +14.4% ▲ | |
| 37 | 1,005 | £142 | +37.7% ▲ | |
| Modafinil | 36 | 2,212 | £153 | +72.7% ▲ |
| Ethosuximide | 36 | 9,921 | £10.0K | +144.0% ▲ |
| Amantadine hydrochloride | 36 | 2,215 | £646 | +29.2% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.